KR20220151183A - 하이브리드화 연쇄 반응을 통한 샘플 내의 표적 분자의 분석 - Google Patents
하이브리드화 연쇄 반응을 통한 샘플 내의 표적 분자의 분석 Download PDFInfo
- Publication number
- KR20220151183A KR20220151183A KR1020227034305A KR20227034305A KR20220151183A KR 20220151183 A KR20220151183 A KR 20220151183A KR 1020227034305 A KR1020227034305 A KR 1020227034305A KR 20227034305 A KR20227034305 A KR 20227034305A KR 20220151183 A KR20220151183 A KR 20220151183A
- Authority
- KR
- South Korea
- Prior art keywords
- hcr
- initiator
- probe
- sample
- fractionation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000009396 hybridization Methods 0.000 title abstract description 45
- 238000006243 chemical reaction Methods 0.000 title abstract description 41
- 238000004458 analytical method Methods 0.000 title description 13
- 238000009739 binding Methods 0.000 claims abstract description 392
- 230000027455 binding Effects 0.000 claims abstract description 391
- 238000000034 method Methods 0.000 claims abstract description 293
- 238000001514 detection method Methods 0.000 claims abstract description 147
- 230000008021 deposition Effects 0.000 claims abstract description 19
- 239000000523 sample Substances 0.000 claims description 2606
- 239000003999 initiator Substances 0.000 claims description 1206
- 238000005194 fractionation Methods 0.000 claims description 558
- 239000000178 monomer Substances 0.000 claims description 287
- 239000000758 substrate Substances 0.000 claims description 269
- 238000005406 washing Methods 0.000 claims description 226
- 239000003623 enhancer Substances 0.000 claims description 219
- 230000000295 complement effect Effects 0.000 claims description 142
- 150000007523 nucleic acids Chemical group 0.000 claims description 103
- 102000039446 nucleic acids Human genes 0.000 claims description 92
- 108020004707 nucleic acids Proteins 0.000 claims description 92
- 102000004190 Enzymes Human genes 0.000 claims description 68
- 108090000790 Enzymes Proteins 0.000 claims description 68
- 108090000623 proteins and genes Proteins 0.000 claims description 57
- 102000004169 proteins and genes Human genes 0.000 claims description 56
- 239000000126 substance Substances 0.000 claims description 43
- 230000008685 targeting Effects 0.000 claims description 35
- 239000002773 nucleotide Substances 0.000 claims description 28
- 125000003729 nucleotide group Chemical group 0.000 claims description 28
- 239000003795 chemical substances by application Substances 0.000 claims description 25
- 238000002866 fluorescence resonance energy transfer Methods 0.000 claims description 24
- 230000002708 enhancing effect Effects 0.000 claims description 18
- 238000011534 incubation Methods 0.000 claims description 17
- 230000004807 localization Effects 0.000 claims description 12
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 8
- 230000008878 coupling Effects 0.000 claims description 8
- 238000010168 coupling process Methods 0.000 claims description 8
- 238000005859 coupling reaction Methods 0.000 claims description 8
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 claims description 6
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 claims description 6
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 claims description 6
- 229910052761 rare earth metal Inorganic materials 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- 210000001255 hallux Anatomy 0.000 claims description 5
- 210000000453 second toe Anatomy 0.000 claims description 5
- 229960002685 biotin Drugs 0.000 claims description 4
- 235000020958 biotin Nutrition 0.000 claims description 4
- 239000011616 biotin Substances 0.000 claims description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- 230000002285 radioactive effect Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 39
- 230000003197 catalytic effect Effects 0.000 abstract description 10
- 230000003321 amplification Effects 0.000 description 149
- 238000003199 nucleic acid amplification method Methods 0.000 description 149
- 229920000642 polymer Polymers 0.000 description 125
- 230000000875 corresponding effect Effects 0.000 description 124
- 238000006116 polymerization reaction Methods 0.000 description 64
- 229940088598 enzyme Drugs 0.000 description 59
- 108020004414 DNA Proteins 0.000 description 58
- 108020004999 messenger RNA Proteins 0.000 description 51
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 50
- 238000003556 assay Methods 0.000 description 47
- 238000003384 imaging method Methods 0.000 description 39
- 238000011065 in-situ storage Methods 0.000 description 29
- 238000003776 cleavage reaction Methods 0.000 description 28
- 230000007017 scission Effects 0.000 description 28
- 230000002779 inactivation Effects 0.000 description 27
- 238000013467 fragmentation Methods 0.000 description 23
- 238000006062 fragmentation reaction Methods 0.000 description 23
- 230000001965 increasing effect Effects 0.000 description 22
- 239000003153 chemical reaction reagent Substances 0.000 description 20
- 150000001413 amino acids Chemical class 0.000 description 18
- 230000000977 initiatory effect Effects 0.000 description 18
- 230000006911 nucleation Effects 0.000 description 17
- 238000010899 nucleation Methods 0.000 description 17
- 238000007901 in situ hybridization Methods 0.000 description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 108020005004 Guide RNA Proteins 0.000 description 14
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 14
- 239000002853 nucleic acid probe Substances 0.000 description 14
- 239000000975 dye Substances 0.000 description 13
- 210000002257 embryonic structure Anatomy 0.000 description 13
- 150000003384 small molecules Chemical class 0.000 description 13
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 12
- 238000013459 approach Methods 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 230000001404 mediated effect Effects 0.000 description 11
- 238000007837 multiplex assay Methods 0.000 description 11
- 241000894007 species Species 0.000 description 11
- 230000001629 suppression Effects 0.000 description 11
- 230000008901 benefit Effects 0.000 description 10
- -1 dinitrophenyl Chemical group 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 238000013461 design Methods 0.000 description 9
- 238000002372 labelling Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 238000005192 partition Methods 0.000 description 9
- 238000001228 spectrum Methods 0.000 description 9
- 239000012491 analyte Substances 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 238000004132 cross linking Methods 0.000 description 8
- 238000003364 immunohistochemistry Methods 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 238000001338 self-assembly Methods 0.000 description 8
- 108091023037 Aptamer Proteins 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 230000035515 penetration Effects 0.000 description 7
- 230000007547 defect Effects 0.000 description 6
- 239000007850 fluorescent dye Substances 0.000 description 6
- 210000001161 mammalian embryo Anatomy 0.000 description 6
- 238000005457 optimization Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000011534 wash buffer Substances 0.000 description 6
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 5
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 5
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 5
- 108020005198 Long Noncoding RNA Proteins 0.000 description 5
- 239000011324 bead Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000000684 flow cytometry Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 229920000669 heparin Polymers 0.000 description 5
- 229960002897 heparin Drugs 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 230000009871 nonspecific binding Effects 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 230000000717 retained effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 239000003298 DNA probe Substances 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 108090001007 Interleukin-8 Proteins 0.000 description 4
- 108010085220 Multiprotein Complexes Proteins 0.000 description 4
- 102000007474 Multiprotein Complexes Human genes 0.000 description 4
- 108010090804 Streptavidin Proteins 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000003398 denaturant Substances 0.000 description 4
- 230000002349 favourable effect Effects 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000012083 mass cytometry Methods 0.000 description 4
- 239000002679 microRNA Substances 0.000 description 4
- 238000002493 microarray Methods 0.000 description 4
- 238000000386 microscopy Methods 0.000 description 4
- 229920000136 polysorbate Polymers 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000004544 DNA amplification Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108091092584 GDNA Proteins 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108700011259 MicroRNAs Proteins 0.000 description 3
- 108091093037 Peptide nucleic acid Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000002820 assay format Methods 0.000 description 3
- 238000000701 chemical imaging Methods 0.000 description 3
- 230000000368 destabilizing effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000000799 fluorescence microscopy Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 108091027963 non-coding RNA Proteins 0.000 description 3
- 102000042567 non-coding RNA Human genes 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000004850 protein–protein interaction Effects 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 238000012772 sequence design Methods 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- KZMAWJRXKGLWGS-UHFFFAOYSA-N 2-chloro-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-n-(3-methoxypropyl)acetamide Chemical compound S1C(N(C(=O)CCl)CCCOC)=NC(C=2C=CC(OC)=CC=2)=C1 KZMAWJRXKGLWGS-UHFFFAOYSA-N 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 2
- 241000252212 Danio rerio Species 0.000 description 2
- 241000257465 Echinoidea Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 108091027967 Small hairpin RNA Proteins 0.000 description 2
- 108020004459 Small interfering RNA Proteins 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- 229960000074 biopharmaceutical Drugs 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 239000002981 blocking agent Substances 0.000 description 2
- 239000008364 bulk solution Substances 0.000 description 2
- 238000005251 capillar electrophoresis Methods 0.000 description 2
- 230000008045 co-localization Effects 0.000 description 2
- 230000002079 cooperative effect Effects 0.000 description 2
- 229960000633 dextran sulfate Drugs 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- VUSHQLWDOJFSGF-UHFFFAOYSA-L disodium 3-carboxy-3,5-dihydroxy-5-oxopentanoate chloride Chemical compound [Na+].[Na+].Cl.[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O VUSHQLWDOJFSGF-UHFFFAOYSA-L 0.000 description 2
- 238000002296 dynamic light scattering Methods 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000000834 fixative Substances 0.000 description 2
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 108091070501 miRNA Proteins 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 150000002910 rare earth metals Chemical class 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002924 silencing RNA Substances 0.000 description 2
- 239000004055 small Interfering RNA Substances 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- FGRBYDKOBBBPOI-UHFFFAOYSA-N 10,10-dioxo-2-[4-(N-phenylanilino)phenyl]thioxanthen-9-one Chemical compound O=C1c2ccccc2S(=O)(=O)c2ccc(cc12)-c1ccc(cc1)N(c1ccccc1)c1ccccc1 FGRBYDKOBBBPOI-UHFFFAOYSA-N 0.000 description 1
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 1
- 241001455214 Acinonyx jubatus Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 108091032955 Bacterial small RNA Proteins 0.000 description 1
- 241000272194 Ciconiiformes Species 0.000 description 1
- 102100035176 Coiled-coil alpha-helical rod protein 1 Human genes 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 241000408659 Darpa Species 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241001115868 Ectopistes Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000256602 Isoptera Species 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- 241001503471 Mammuthus primigenius Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000282579 Pan Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 241000283080 Proboscidea <mammal> Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241001115903 Raphus cucullatus Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 108010003723 Single-Domain Antibodies Proteins 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 238000003271 compound fluorescence assay Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000001317 epifluorescence microscopy Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000002826 magnetic-activated cell sorting Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 238000001531 micro-dissection Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 108091008104 nucleic acid aptamers Proteins 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000021715 photosynthesis, light harvesting Effects 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000007781 signaling event Effects 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000012096 transfection reagent Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/682—Signal amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6832—Enhancement of hybridisation reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6841—In situ hybridisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/30—Oligonucleotides characterised by their secondary structure
- C12Q2525/301—Hairpin oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2543/00—Reactions characterised by the reaction site, e.g. cell or chromosome
- C12Q2543/10—Reactions characterised by the reaction site, e.g. cell or chromosome the purpose being "in situ" analysis
- C12Q2543/101—Reactions characterised by the reaction site, e.g. cell or chromosome the purpose being "in situ" analysis in situ amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062986436P | 2020-03-06 | 2020-03-06 | |
| US62/986,436 | 2020-03-06 | ||
| PCT/US2021/020919 WO2021221789A2 (en) | 2020-03-06 | 2021-03-04 | Analysis of target molecules within a sample via hybridization chain reaction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20220151183A true KR20220151183A (ko) | 2022-11-14 |
Family
ID=78332110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020227034305A Pending KR20220151183A (ko) | 2020-03-06 | 2021-03-04 | 하이브리드화 연쇄 반응을 통한 샘플 내의 표적 분자의 분석 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20220282300A1 (https=) |
| EP (2) | EP4114969B1 (https=) |
| JP (2) | JP2023517054A (https=) |
| KR (1) | KR20220151183A (https=) |
| CN (1) | CN115516105A (https=) |
| AU (1) | AU2021265719A1 (https=) |
| CA (1) | CA3173975A1 (https=) |
| IL (1) | IL295981A (https=) |
| WO (1) | WO2021221789A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL290679B2 (en) | 2016-07-05 | 2023-10-01 | California Inst Of Techn | Hybridization chain reaction based on a minimal initiator |
| GB202100760D0 (en) * | 2021-01-20 | 2021-03-03 | Qbiotix Ltd | Target-dependent polymerisation of oligonucleotides |
| WO2022164796A1 (en) | 2021-01-26 | 2022-08-04 | California Institute Of Technology | Allosteric conditional guide rnas for cell-selective regulation of crispr/cas |
| EP4482982A1 (en) | 2022-02-21 | 2025-01-01 | Kanvas Biosciences, Inc | Highly multiplexed detection of gene expression with hybridization chain reaction |
| CN115961011B (zh) * | 2022-12-19 | 2025-04-08 | 中山大学 | 一种基于金纳米粒子和杂交链反应扩增检测甲醛的方法 |
| CN116206684B (zh) * | 2022-12-26 | 2024-01-30 | 纳昂达(南京)生物科技有限公司 | 一种评估基因组重复区探针捕获安全性的方法及其装置 |
| US20240336956A1 (en) | 2023-04-04 | 2024-10-10 | California Institute Of Technology | Ultrasensitive molecular detection via hybridization chain reaction |
| US20250011843A1 (en) * | 2023-07-07 | 2025-01-09 | California Institute Of Technology | Molecular detection using barcode probes or barcode fusion probes and hybridization chain reaction |
| WO2025076345A1 (en) * | 2023-10-06 | 2025-04-10 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Compositions and methods for identifying bacterial characteristics |
| GB202402960D0 (en) * | 2024-02-29 | 2024-04-17 | Nanovery Ltd | Catalytic nucleic acid system |
| CN121653230A (zh) * | 2026-02-06 | 2026-03-13 | 中国科学技术大学 | 高通量原位检测生物样品内核酸分子的探针组、试剂盒和方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005098049A2 (en) | 2004-03-25 | 2005-10-20 | California Institute Of Technology | Hybridization chain reaction |
| EP1799825B1 (en) * | 2004-10-05 | 2011-06-29 | The California Institute of Technology | Aptamer regulated nucleic acids and uses thereof |
| US7727721B2 (en) | 2005-03-08 | 2010-06-01 | California Institute Of Technology | Hybridization chain reaction amplification for in situ imaging |
| DK2444807T3 (da) * | 2006-11-01 | 2014-08-11 | Ventana Med Syst Inc | Mono- og dinitropyrazolhaptenkonjugater |
| US8793705B2 (en) | 2007-08-31 | 2014-07-29 | Red Hat, Inc. | Rich internet bus |
| GB201401885D0 (en) * | 2014-02-04 | 2014-03-19 | Olink Ab | Proximity assay with detection based on hybridisation chain reaction (HCR) |
| US10364457B2 (en) | 2015-08-07 | 2019-07-30 | Massachusetts Institute Of Technology | Nanoscale imaging of proteins and nucleic acids via expansion microscopy |
| EP4613756A3 (en) | 2016-04-25 | 2025-11-12 | President And Fellows Of Harvard College | Hybridization chain reaction methods for in situ molecular detection |
| IL290679B2 (en) * | 2016-07-05 | 2023-10-01 | California Inst Of Techn | Hybridization chain reaction based on a minimal initiator |
| CA3034617A1 (en) * | 2016-08-30 | 2018-03-08 | California Institute Of Technology | Immunohistochemistry via hybridization chain reaction |
| US11459603B2 (en) * | 2017-05-23 | 2022-10-04 | Rutgers, The State University Of New Jersey | Target mediated in situ signal amplification with dual interacting hairpin probes |
-
2021
- 2021-03-04 IL IL295981A patent/IL295981A/en unknown
- 2021-03-04 US US17/637,253 patent/US20220282300A1/en active Pending
- 2021-03-04 WO PCT/US2021/020919 patent/WO2021221789A2/en not_active Ceased
- 2021-03-04 EP EP21796673.8A patent/EP4114969B1/en active Active
- 2021-03-04 CN CN202180033401.5A patent/CN115516105A/zh active Pending
- 2021-03-04 JP JP2022553645A patent/JP2023517054A/ja active Pending
- 2021-03-04 EP EP25177772.8A patent/EP4592389A3/en active Pending
- 2021-03-04 AU AU2021265719A patent/AU2021265719A1/en active Pending
- 2021-03-04 CA CA3173975A patent/CA3173975A1/en active Pending
- 2021-03-04 KR KR1020227034305A patent/KR20220151183A/ko active Pending
-
2022
- 2022-02-28 US US17/682,336 patent/US20230193362A1/en active Pending
-
2026
- 2026-01-09 JP JP2026002791A patent/JP2026065072A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4114969B1 (en) | 2025-08-06 |
| JP2026065072A (ja) | 2026-04-14 |
| EP4114969C0 (en) | 2025-08-06 |
| US20230193362A1 (en) | 2023-06-22 |
| US20220282300A1 (en) | 2022-09-08 |
| WO2021221789A3 (en) | 2022-03-24 |
| CN115516105A (zh) | 2022-12-23 |
| EP4592389A3 (en) | 2025-08-13 |
| EP4114969A2 (en) | 2023-01-11 |
| CA3173975A1 (en) | 2021-11-04 |
| EP4114969A4 (en) | 2024-03-06 |
| IL295981A (en) | 2022-10-01 |
| EP4592389A2 (en) | 2025-07-30 |
| JP2023517054A (ja) | 2023-04-21 |
| WO2021221789A2 (en) | 2021-11-04 |
| AU2021265719A1 (en) | 2022-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20220151183A (ko) | 하이브리드화 연쇄 반응을 통한 샘플 내의 표적 분자의 분석 | |
| US12435359B2 (en) | Fractional initiator hybridization chain reaction | |
| US20250179562A1 (en) | Ultrasensitive molecular detection via hybridization chain reaction | |
| HK40085562A (en) | Analysis of target molecules within a sample via hybridization chain reaction | |
| HK40062706A (en) | Fractional initiator hybridization chain reaction | |
| HK40062706B (en) | Fractional initiator hybridization chain reaction | |
| WO2025132546A1 (en) | Method for reducing nonspecific signals in in-situ hybridization assays | |
| HK40008988B (en) | Fractional initiator hybridization chain reaction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20220930 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application |